Abstract
prohormone may have particularly detrimental metabolic effects in the pathogenesis of cardiovascular disease (CVD) or metabolic syndrome.
Among both diabetic and nondiabetic subjects, proinsulin has exhibited moderate but significant associations with blood pressure (BP) and concentrations of total cholesterol, triglycerides, LDL and HDL cholesterol [9] [10] [11] , independent of other factors included in multivariate analyses.
Several studies have suggested that plasma proinsulin concentrations and the proinsulin-toinsulin ratio may be better related to cardiovascular risk factors (in particular, increased blood pressure and higher triglyceride levels) as compared to plasma insulin concentrations [12, 13] . However, the role of elevated proinsulin in atherogenesis remains controversial [14] .
The aim of the present study was to determine the discriminating values of proinsulin, proinsulin-to-insulin ratio (PIR), proinsulin-to-C-peptide ratio (PCPR) and HOMA-IR as predictors for the metabolic syndrome as well as discovering the sex-specific cutoff points of these parameters in Romanian population.
Materials and Methods

Study population and sampling methods
A cross-sectional, population-based screening campaign whose main objective was the screening for diabetes took place between November-December 2011 in Bucharest, Romania. During this campaign a total of over 15,000 people were assessed. Only data from patients who gave their informed consent were analyzed and processed. The exclusion criteria were: patients with a previous diagnosis of diabetes, pregnancy, patients having an alcohol consumption of more than 20 g/day for women and 30 g/day for men, history of pancreatitis, chronic liver disease, autoimmune liver disease, hemochromatosis, HIV infection, patients with history of hepatotoxic or steatosis-inducing drug use, currently on interferon treatment or during the last 12 months, recent surgery, inflammatory or malignant disease, anticoagulant therapy, steroid therapy, postmenopausal women on estrogen replacement therapy. Finally, a random population-based sample (n=656) of Romanians (26-80 years) was studied. Of these, 432 persons had diabetes and they were not analyzed for this paper so that the study group finally included 224 subjects.
Procedures and Measurements
Participants underwent an extensive interview for information on current medications, medical history, smoking, physical activity, etc. Anthropometric indices were measured with participants lightly dressed and barefoot. Body mass index (BMI) was calculated as weight (in kilograms)/height (in meters) squared. Waist and hip circumferences were measured at the level of the umbilicus, and at the level of the maximum perimeter between the iliac crest and the crotch, respectively.
The presence of MetS (score ≥3/5) was defined according to the joint harmonized International Diabetes Federation (IDF), National Heart, Lung, and Blood Institute (NHLBI), American Heart Association (AHA), World Heart Federation (WHF), International Atherosclerosis Society (IAS), International Association for the Study of Obesity (IASO) criteria [15, 16] . Metabolic circumference (metabolic WC) was defined as waist circumference ≥94 cm for men and ≥80 cm for women.
Percentage body fat (BF%) was predicted using an equation developed in Dutch Caucasians which include BMI, age, and sex [17] : BF% = 1.2xBMI + 0.23xage -10.8xsex -5.4, where age is in years and sex = 0 in females and 1 in males.
Laboratory assays
Fasting blood samples were drawn between 7:00 a.m. and 10:00 a.m. The biochemical analyses, including fasting plasma glucose (FPG), fasting plasma insulin (FPI), fasting plasma proinsulin (FPP), fasting plasma Cpeptide, HbA1c, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), creatinine, urea, were measured after an overnight fasting period of 12h, using routine clinical chemistry methods and then documented.
Intact proinsulin was measured using an ELISA kit (Demeditec Diagnostics GmbH, Germany). The inter-and intra-assay CVs was 4.3% and 5.5% for proinsulin. Serum insulin and C-peptide were determined by chemiluminescence enzyme immunoassay (Architect, Abbott). The cross-reactivity of insulin with proinsulin, and with C-peptide was 0.1%, respectively 0.001%.
Insulin resistance (IR) was determined using the Homeostasis model assessment for insulin resistance (HOMA-IR) formula: fasting insulin level (mUI/l)x fasting glucose level (mg/dl)/405 [18] . A HOMA-IR index value of more than 2.0 was considered as the criteria of insulin resistance. The homeostatic model for assessment of B-cell function (HOMA-B) was calculated using the formula [18]: 20×FPI (μU/ml)/(FPG (mmol/l) -3.5. The quantitative insulin sensitivity check index (QUICKI) was calculated using the formula: 1/(log (FPI) (μU/ml)+log (FPG) (mg/dl)) [19] .
Statistical Analyses
Values were expressed as means ± SD for normally distributed data or median (range) for skewed data. Log transformation was also applied to skewed data for insulin, triglyceride (TG), HOMA-IR, C-peptide, proinsulin, PIR, and PCPR. Comparisons among groups were made by use of ANOVA for quantitative variables and the χ 2 test of independence for categorical variables. The area under the Receiver's Operating characteristic Curve (ROC) -AUROC -and the 95% confidence intervals (CIs) were used to compare the predictive ability of the tested parameters. The AUC is a measure of the degree of separation between case and control subjects.
Spearman correlation test was used to summarize the association between FPP, FPI, PIR, PCPR and MetS components. Logistic regression model was used to estimate odds ratios (OR s) and 95 percent confidence intervals. Multivariate logistic regression analysis was used to estimate the adjusted odds ratios (OR) and the 95% confidence intervals of FPP, FPI, PIR, PCPR, HOMA-IR in predicting MetS. The level of significance was set at p≤0.05.
Results
Among the 224 patients (87 males and 137 females), MetS was diagnosed in 97 patients (43.3%) according to the modified IDF criteria [15, 16] . After stratification by gender, 43 men (49.4%) and 54 women (39.4%), had MetS. Table 1 summarizes the general characteristics of the study group according to gender, including anthropometric and lab parametres. There were statistically significant differences between sexes for BMI, %BF, FPG, HDL-C, FPP, PIR, PCPR, HOMA-B (all p<0.05).
The presence of the metabolic syndrome components was similar in women in comparison to men (Table 2) .
Baseline and demographic characteristics of the patients with MetS versus patients without MetS (according to the IDF criteria) [15, 16] are summarized in Table 3 . The prevalence of MetS increased with age (p<0.0001). Patients presenting MetS were older, and they had a higher BMI, % BF, and systolic blood pressure (SBP), higher values of TG, FPG, HbA1c, FPI, C-Peptide, FPP, PIR, PCPR, HOMA-IR and lower values of HDL-C, Quicki index (all p<0.05). 
Comparison of areas under ROC curves (95% CI) for predictors of MetS, categorized by gender
In all patients, ROC analysis showed that HOMA-IR (AUROC = 0.756 (95% CI: 0.695, 0.818)) was the strongest predictor of MetS, followed by FPP (AUROC = 0.755 (95% CI: 0.693, 0.818)) and TG (AUROC=0.788 (95% CI: 0.727, 0.850)) (overall p< 0.0001) ( Table 4 ; Figure 1 ). In women all tested variables showed discriminative ability, with an AUROC significantly different from 0. Figure 2) .
In men HOMA-IR (AUROC = 0.797 (95% CI: 0.707, 0.888)) was the strongest predictor of MetS followed by FPP (AUROC = 0.786 (95% CI: 0.690, 0.882)), and FPI (AUROC=0.734 (95% CI: 0.631, 0.837)) (overall p < 0.05) ( Table 4 ; Figure 3) .
The cutoff value for TG was 138.5 mg/dl (137 mg/dl in women and 139 mg/dl in men), for HOMA-IR was 1.85 (1.85 in women and 1.67 in men) and for FPP was 4.75 pmol/L (3.52 pmol/L in women and 4.78 pmol/L in men). All these parameters have a high sensitivity but low specificity for identifying MetS as shown in Table 5 . A significant risk for MetS was observed among the patients over 57.7 years, with higher BMI, %BF, FPI, FPP, PIR, PCPR, HOMA-IR (Table 7) . On multivariate logistic regression analysis, only age, BMI, FPP, and HOMA-IR were the only independent factors associated with presence of MetS (Table 7) . 
Discussions
The metabolic syndrome is an important risk factor for type 2 diabetes (T2DM) and cardiovascular diseases. Thus, the main clinical implication of a MetS diagnosis is the identification of patients who need aggressive lifestyle modification [20, 21] . The results of this study showed that the prevalence of metabolic syndrome is high in the studied population and it increases significantly with age and BMI. Thus, the prevalence of MetS in this study (according to the modified IDF criteria [15, 16] ) was 43.3%. After stratification by gender, 43 men (49.4%) and 54 women (39.4%) had MetS. The prevalence of MetS in our study was higher than previously published in Romania [22] and in most European countries [23] . Patients included in this study were randomly selected following a screening campaign for diabetes. A possible explanation for this increased prevalence is the participation in a higher percentage of patients already presenting other metabolic disturbances.
The prevalence of obesity in our study was 30.4% (n=68), 25.3% (n=22) in men and 33.6% (n=46) in women. We also observed a higher prevalence of obesity than previously reported [24] .
In the present study FPP and HOMA-IR were the best predictors in multivariate analysis for MetS; FPI, PIR, and PCPR were not associated with metabolic syndrome in multivariate models.
There are multiple definitions of the metabolic syndrome according to cutoff values for its components. In our study the best predictor for MetS in all patients and in women was TG, followed by HOMA-IR and FPP; in men the best predictor was HOMA-IR, followed by FPP and FPI. All these parameters have a high sensitivity but low specificity for identifying metabolic syndrome.
In our study the median fasting plasma proinsulin concentration was 4.33 (2.53-7.16) pmol/L, higher in men than in women (5.1 pmol/L (3.18-8.64) vs. 3.6 pmol/L (2.16-6.59)). These results are similar to those previously reported [25] [26] [27] [28] [29] [30] .
Similar with our study, Haffner et al. found that FPP was significantly correlated with TG levels, increased BP, and decreased HDL-C in non-diabetic patients [10] . Similar results were obtained by Nagi et al. but in diabetic subjects [9] . Haffner et al. and Nagi et al. found that FPI was more strongly associated with BMI than proinsulin concentrations [9, 10] . Similar with other studies, we found that FPP was strongly associated with insulin resistance [31] .
Our study has several limitations. First, this was a non-randomized study, with a crosssectional design and it has a limited ability to eliminate causal relationships between FPP, FPI, HOMA-IR and MetS. Second, our definition of insulin resistance is based on HOMA-IR.
Conclusions
In conclusion, the present study showed that FPP and HOMA-IR were the best predictors in multivariate analysis for MetS; FPI, PIR, and PCPR were not associated with metabolic syndrome in multivariate models. Our results indicate that regardless of gender HOMA-IR and FPP could be the preferred parameters for predicting metabolic syndrome. These parameters enable the early identification of MetS, allow precocious treatment and therefore represent a major issue for the health care professionals.
